A Phase III, Open-label, Randomized Study of the Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase of Trial: Phase III
Latest Information Update: 03 Feb 2017
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Registrational; Therapeutic Use
- Sponsors Orient Europharma
- 07 Jun 2017 Biomarkers information updated
- 13 Nov 2016 Planned End Date changed from 1 Sep 2018 to 1 Mar 2018.
- 13 Nov 2016 Planned primary completion date changed from 1 Sep 2018 to 1 Mar 2018.